 I. To determine the rate of conversion to full donor chimerism FDC following a post transplant infusion day 30-60 of freshly enriched allogeneic CD8 memory T-cells in patients with acute myeloid leukemia AML, non-Hodgkin lymphoma NHL, chronic lymphocytic leukemia CLL, or Hodgkin lymphoma HL, who received non-myeloablative total lymphoid irradiation TLI anti-thymocyte globulin ATG transplant conditioning. 